Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.28 USD | -0.92% | -8.06% | -26.94% |
09-04 | Jefferies Initiates Nextracker at Hold With $46 Price Target | MT |
08-02 | UBS Adjusts Price Target on Nextracker to $67 From $65, Maintains Buy Rating | MT |
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Revenues | 1.17B | 1.2B | 1.46B | 1.9B | 2.5B | |
Total Revenues | 1.17B | 1.2B | 1.46B | 1.9B | 2.5B | |
Cost of Goods Sold, Total | 958M | 964M | 1.31B | 1.62B | 1.81B | |
Gross Profit | 213M | 232M | 147M | 287M | 692M | |
Selling General & Admin Expenses, Total | 55.36M | 60.44M | 66.95M | 95.34M | 184M | |
R&D Expenses | 8.64M | 13.01M | 14.18M | 21.62M | 42.36M | |
Other Operating Expenses | - | - | - | - | -121M | |
Other Operating Expenses, Total | 64M | 73.45M | 81.12M | 117M | 105M | |
Operating Income | 149M | 159M | 65.91M | 170M | 587M | |
Interest Expense, Total | - | -20K | -34K | -1.83M | -13.82M | |
Interest And Investment Income | 144K | - | - | - | - | |
Net Interest Expenses | 144K | -20K | -34K | -1.83M | -13.82M | |
Other Non Operating Income (Expenses) | -120K | -482K | -765K | 2.43M | 34.7M | |
EBT, Excl. Unusual Items | 149M | 158M | 65.11M | 171M | 608M | |
Legal Settlements | - | - | - | -1.53M | - | |
EBT, Incl. Unusual Items | 149M | 158M | 65.11M | 169M | 608M | |
Income Tax Expense | 30.67M | 33.68M | 14.2M | 47.75M | 112M | |
Earnings From Continuing Operations | 118M | 124M | 50.91M | 121M | 496M | |
Net Income to Company | 118M | 124M | 50.91M | 121M | 496M | |
Minority Interest | - | - | - | -2.45M | -190M | |
Net Income - (IS) | 118M | 124M | 50.91M | 119M | 306M | |
Preferred Dividend and Other Adjustments | - | - | - | 118M | - | |
Net Income to Common Incl Extra Items | 118M | 124M | 50.91M | 1.14M | 306M | |
Net Income to Common Excl. Extra Items | 118M | 124M | 50.91M | 1.14M | 306M | |
Per Share Items | ||||||
Net EPS - Basic | - | - | - | 0.02 | 3.97 | |
Basic EPS - Continuing Operations | - | - | - | 0.02 | 3.97 | |
Basic Weighted Average Shares Outstanding | - | - | - | 45.89M | 77.07M | |
Net EPS - Diluted | - | - | - | 0.02 | 3.37 | |
Diluted EPS - Continuing Operations | - | - | - | 0.02 | 3.37 | |
Diluted Weighted Average Shares Outstanding | - | - | - | 146M | 147M | |
Normalized Basic EPS | - | - | - | 2.27 | 2.47 | |
Normalized Diluted EPS | - | - | - | 0.71 | 1.29 | |
Payout Ratio | - | 266.51 | - | - | - | |
Supplemental Items | ||||||
EBITDA | 167M | 175M | 77.05M | 175M | 591M | |
EBITA | 164M | 174M | 74.37M | 171M | 587M | |
EBIT | 149M | 159M | 65.91M | 170M | 587M | |
EBITDAR | 168M | 177M | 78.82M | 177M | 594M | |
Effective Tax Rate - (Ratio) | 20.6 | 21.31 | 21.8 | 28.24 | 18.39 | |
Current Domestic Taxes | 34.87M | 34.01M | 13.56M | 35.24M | 65.29M | |
Current Foreign Taxes | 460K | 2K | 5.97M | 18.24M | 7.9M | |
Total Current Taxes | 35.33M | 34.02M | 19.53M | 53.48M | 73.19M | |
Deferred Domestic Taxes | -5.24M | 54K | -6.17M | -8.66M | 30.5M | |
Deferred Foreign Taxes | 578K | -388K | 836K | 2.93M | 8.1M | |
Total Deferred Taxes | -4.66M | -334K | -5.34M | -5.73M | 38.59M | |
Normalized Net Income | 93.08M | 98.77M | 40.69M | 104M | 190M | |
Supplemental Operating Expense Items | ||||||
General and Administrative Expenses | - | 2.35M | - | - | - | |
Research And Development Expense From Footnotes | 8.64M | 13.01M | 14.18M | 21.62M | 42.36M | |
Net Rental Expense, Total | 1.5M | 1.62M | 1.77M | 1.92M | 2.28M | |
Imputed Operating Lease Interest Expense | - | 52.49K | 107K | 364K | 1.6M | |
Imputed Operating Lease Depreciation | - | 1.57M | 1.66M | 1.56M | 683K | |
Stock-Based Comp., COGS (Total) | 1.64M | 1.95M | 1.53M | 12.79M | 10.76M | |
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | 7.69M | |
Stock-Based Comp., G&A Exp. (Total) | - | 2.35M | - | - | - | |
Stock-Based Comp., SG&A Exp. (Total) | 2.59M | - | 1.52M | 19.2M | 38.32M | |
Total Stock-Based Compensation | 4.24M | 4.31M | 3.05M | 31.99M | 56.78M |